Chronic myeloid leukemia (CML) is a clonal expansion of the progenitor hematopoietic stem cells arising from the existence of the fusion BCR-ABL oncogene, that represents 15%-20% of the newly diagnosed cases of leukemia patients 1-2. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.